Title : Induction of aldo-keto reductases (AKR1C1 and AKR1C3) abolishes the efficacy of daunorubicin chemotherapy for leukemic U937 cells.

Pub. Date : 2014 Sep

PMID : 24743520






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Induction of aldo-keto reductases (AKR1C1 and AKR1C3) abolishes the efficacy of daunorubicin chemotherapy for leukemic U937 cells. Daunorubicin aldo-keto reductase family 1 member C1 Homo sapiens